UA97737U - NECROXIDE Ointment for the treatment of purulent-necrotic lesions of the skin in necrobacteriosis in cattle - Google Patents

NECROXIDE Ointment for the treatment of purulent-necrotic lesions of the skin in necrobacteriosis in cattle

Info

Publication number
UA97737U
UA97737U UAU201404148U UAU201404148U UA97737U UA 97737 U UA97737 U UA 97737U UA U201404148 U UAU201404148 U UA U201404148U UA U201404148 U UAU201404148 U UA U201404148U UA 97737 U UA97737 U UA 97737U
Authority
UA
Ukraine
Prior art keywords
ointment
necroxide
necrobacteriosis
purulent
treatment
Prior art date
Application number
UAU201404148U
Other languages
Russian (ru)
Ukrainian (uk)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to UAU201404148U priority Critical patent/UA97737U/en
Publication of UA97737U publication Critical patent/UA97737U/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Мазь "Некроксид" для лікування гнійно-некротичних уражень шкіри при некробактеріозі у великої рогатої худоби включає гідрофільну основу. Мазь складається з наступних компонентів, в г: цефтріаксон - 1,0; стрептоцид - 4,0; поліетіленоксид-400 - 76,0; поліетіленоксид-1500 - 19,0. Мазь не містить формоутворювачів.Necroxide ointment for the treatment of purulent-necrotic skin lesions in necrobacteriosis in cattle includes a hydrophilic base. The ointment consists of the following components, in g: ceftriaxone - 1.0; streptocide - 4.0; polyethylene oxide-400 - 76,0; polyethylene oxide-1500 - 19.0. The ointment contains no formants.

UAU201404148U 2014-04-17 2014-04-17 NECROXIDE Ointment for the treatment of purulent-necrotic lesions of the skin in necrobacteriosis in cattle UA97737U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201404148U UA97737U (en) 2014-04-17 2014-04-17 NECROXIDE Ointment for the treatment of purulent-necrotic lesions of the skin in necrobacteriosis in cattle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201404148U UA97737U (en) 2014-04-17 2014-04-17 NECROXIDE Ointment for the treatment of purulent-necrotic lesions of the skin in necrobacteriosis in cattle

Publications (1)

Publication Number Publication Date
UA97737U true UA97737U (en) 2015-04-10

Family

ID=53501391

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201404148U UA97737U (en) 2014-04-17 2014-04-17 NECROXIDE Ointment for the treatment of purulent-necrotic lesions of the skin in necrobacteriosis in cattle

Country Status (1)

Country Link
UA (1) UA97737U (en)

Similar Documents

Publication Publication Date Title
CL2018002814A1 (en) Compositions and methods for the treatment of wounds, disorders, and skin diseases.
CO2017005784A2 (en) Fused bicyclic compounds for the treatment of diseases
MX2021007268A (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl] amino}acetic acid, compositions, and uses thereof.
CO2017000064A2 (en) Substituted [1,2,4] triazole compounds
CO2017007121A2 (en) Fused bicyclic compounds for the treatment of diseases
UY34657A (en) ? MACROCYCLIC DERIVATIVES FOR THE TREATMENT OF DISEASES ?.
BR112014021104A2 (en) methods and compositions for the treatment of huntington's disease
EA201690513A1 (en) COMBINATION OF MEK INHIBITOR AND ERK INHIBITOR FOR USE IN THE TREATMENT OF HYPERPROLIFERATIVE DISEASES
CL2018000597A1 (en) Methods to treat inflammatory diseases
EA201790627A1 (en) STEMULATORS RHC
WO2019040106A3 (en) Compounds, salts thereof and their use in the treatment of diseases
TR201901348T4 (en) Pyrrolidinone derivatives as metap-2 inhibitors.
MX2021010886A (en) Medicaments for slowing parkinson's disease.
CY1122640T1 (en) TREATMENT AND PREVENTION OF RADIATION DERMATITIS
CY1119532T1 (en) (S) -PYRILDOL AND THE PHARMACEUTALLY ACCEPTABLE SALTS FOR USE IN MEDICINE
MX2017013047A (en) Treatment of pain.
MX2018005987A (en) Heterocyclic compounds for the treatment of disease.
EA201692111A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DANIRYXIN FOR TREATING INFECTIOUS DISEASES
EA201790687A1 (en) QUINOLINCARBOXAMIDE FOR USE IN THE TREATMENT OF MULTIPLE MYELOMA
SG10201805646WA (en) Angiopoietin-like 4 antibodies and methods of use
TR201905218T4 (en) USEFUL VITANOLIDES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES.
MX2020000636A (en) Synthetic proteins and therapeutic uses thereof.
EP3549582A3 (en) Novel capsazepine analogs for the treatment of cancer and other proliferative diseases
MX2019014090A (en) Methods for the treatment of chronic pouchitis.
BR112017011490A2 (en) method for treating ischemic or inflammatory condition in a patient's organ or tissue